Frank A Fazzolari, MD
Gastroenterology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fazzolari’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A75871 · Current
Licensed to practise in California · since 2001 · expires 2027-04-30 · State University of New York Health Science Center at Syracuse.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$150,549
Medicare paid this office $150,549 for 682 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 315 | $75,601 | $240 |
| Biopsy of large bowel using a flexible endoscope | 223 | $15,217 | $68 |
| Short return visit (20+ min) | 120 | $10,902 | $81 |
| Return visit (30+ min) | 79 | $10,032 | $117 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 45 | $9,274 | $206 |
See all 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 315 | $75,601 | $240 |
| Biopsy of large bowel using a flexible endoscope | 223 | $15,217 | $68 |
| Short return visit (20+ min) | 120 | $10,902 | $81 |
| Return visit (30+ min) | 79 | $10,032 | $117 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 45 | $9,274 | $206 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 108 | $8,031 | $72 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,403 | $172 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,266 | $206 |
| Long return visit (40+ min) | 13 | $2,257 | $174 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 20 | $2,249 | $112 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 453 | $2,026 | $4 |
| New patient visit (30+ min) | 12 | $1,294 | $108 |
| Short return visit | 25 | $1,292 | $52 |
| Injection beneath lining of large bowel using a flexible endoscope | 61 | $1,089 | $18 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 24 | $375 | $14 |
Procedures Medicare counted
| Colonoscopy | 110 | More than 82% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 81 | More than 72% of doctors who do this |
Who their Medicare patients are
682 Original Medicare patients in 2024. Average age 74 · Under 65 2% · 85 and older 7% · Women 54% · Also on Medicaid 5% · Health risk score 0.79. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 56% · Coronary heart disease 20% · Cancer 16% · Diabetes 14% · Chronic kidney disease 13% · Atrial fibrillation 13% · Depression 12% · Heart failure 5% · COPD 4% · Dementia 2% · Stroke 2%.
The office billed $1,716,851, Medicare allowed $181,613 and paid $150,549; for 1,597 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 682 | 1,597 | 74 | 0.79 | $1,716,851 | $150,549 |
| 2023 | 568 | 1,238 | 75 | 0.78 | $1,191,214 | $119,559 |
| 2022 | 512 | 1,108 | 75 | 0.85 | $935,031 | $103,595 |
| 2021 | 549 | 1,207 | 75 | 0.82 | $1,039,226 | $112,940 |
| 2020 | 439 | 956 | 75 | 0.91 | $790,123 | $88,517 |
| 2019 | 497 | 1,223 | 74 | 0.90 | $1,069,942 | $111,339 |
| 2018 | 516 | 1,350 | 75 | 0.92 | $1,076,453 | $109,224 |
| 2017 | 540 | 1,319 | 74 | 1.01 | $1,030,079 | $109,908 |
| 2016 | 465 | 828 | 74 | 1.01 | $810,763 | $97,412 |
| 2015 | 455 | 771 | 74 | 0.98 | $840,672 | $113,245 |
| 2014 | 399 | 699 | 74 | 0.96 | $711,572 | $98,160 |
| 2013 | 337 | 574 | 73 | 1.11 | $539,672 | $76,112 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 177 | $43,754 | $246 |
| Biopsy of large bowel using a flexible endoscope | 189 | $20,122 | $106 |
| Short return visit (20+ min) | 110 | $10,469 | $84 |
| Return visit (30+ min) | 83 | $9,984 | $113 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 36 | $7,583 | $211 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 85 | $5,918 | $70 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,322 | $211 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 18 | $2,267 | $126 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 11 | $2,246 | $204 |
| New patient visit (30+ min) | 23 | $2,167 | $94 |
| Short return visit | 29 | $1,746 | $56 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 329 | $1,591 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 32 | $519 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $457 | $19 |
2022: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 143 | $33,360 | $233 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 58 | $12,352 | $213 |
| Biopsy of large bowel using a flexible endoscope | 101 | $10,531 | $104 |
| Short return visit (20+ min) | 114 | $9,862 | $76 |
| Return visit (30+ min) | 81 | $9,750 | $115 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 83 | $6,917 | $80 |
| Biopsy of lower large bowel using a flexible endoscope | 11 | $3,501 | $318 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 11 | $2,782 | $199 |
| New patient visit (30+ min) | 29 | $2,610 | $90 |
| Long return visit (40+ min) | 15 | $2,271 | $151 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 60 | $1,400 | $22 |
| Short return visit | 25 | $1,396 | $52 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 274 | $1,392 | $5 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 13 | $1,294 | $100 |
| Injection beneath lining of large bowel using a flexible endoscope | 26 | $389 | $15 |
2021: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 152 | $35,874 | $236 |
| Biopsy of large bowel using a flexible endoscope | 128 | $14,680 | $115 |
| Short return visit (20+ min) | 153 | $13,978 | $79 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 62 | $13,408 | $216 |
| Return visit (30+ min) | 71 | $8,472 | $116 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 84 | $6,293 | $74 |
| New patient visit (30+ min) | 30 | $2,998 | $100 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 305 | $1,584 | $5 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 13 | $1,513 | $116 |
| Short return visit | 22 | $1,097 | $48 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $823 | $22 |
| Injection beneath lining of large bowel using a flexible endoscope | 51 | $757 | $15 |
2020: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 104 | $25,069 | $241 |
| Biopsy of large bowel using a flexible endoscope | 111 | $13,542 | $122 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 46 | $10,106 | $220 |
| Short return visit (20+ min) | 110 | $8,184 | $67 |
| Return visit (30+ min) | 55 | $5,127 | $90 |
| New patient visit (30+ min) | 48 | $4,855 | $101 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 60 | $4,420 | $72 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 12 | $1,460 | $122 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 231 | $1,206 | $5 |
| Short return visit | 20 | $944 | $45 |
| Injection beneath lining of large bowel using a flexible endoscope | 32 | $485 | $15 |
2019: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 155 | $36,621 | $236 |
| Biopsy of large bowel using a flexible endoscope | 163 | $16,493 | $101 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 48 | $10,347 | $216 |
| Return visit (30+ min) | 89 | $8,974 | $99 |
| Short return visit (20+ min) | 113 | $8,564 | $67 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 66 | $4,387 | $65 |
| New patient visit (30+ min) | 32 | $3,221 | $101 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,590 | $216 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 11 | $1,832 | $167 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 314 | $1,595 | $5 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 15 | $1,548 | $103 |
| Injection beneath lining of large bowel using a flexible endoscope | 48 | $735 | $15 |
2018: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 135 | $31,185 | $231 |
| Biopsy of large bowel using a flexible endoscope | 190 | $21,411 | $113 |
| Return visit (30+ min) | 93 | $9,411 | $91 |
| Short return visit (20+ min) | 106 | $8,598 | $66 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 33 | $6,953 | $211 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 86 | $6,095 | $69 |
| New patient visit (30+ min) | 38 | $3,567 | $94 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $3,190 | $213 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 20 | $2,412 | $115 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 322 | $1,538 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 90 | $1,084 | $11 |
| New patient visit (15+ min) | 15 | $1,004 | $67 |
| Injection beneath lining of large bowel using a flexible endoscope | 57 | $872 | $15 |
2017: 20 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 122 | $28,114 | $230 |
| Biopsy of large bowel using a flexible endoscope | 189 | $20,871 | $110 |
| Return visit (30+ min) | 126 | $13,721 | $94 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 91 | $6,914 | $75 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 32 | $6,788 | $212 |
| Short return visit (20+ min) | 72 | $5,232 | $66 |
| New patient visit (30+ min) | 36 | $3,173 | $88 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 17 | $2,830 | $166 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,548 | $212 |
| Long return visit (40+ min) | 17 | $2,394 | $133 |
| New patient visit (45+ min) | 19 | $2,373 | $125 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 18 | $2,175 | $109 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,125 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,684 | $65 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,260 | $97 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,256 | $90 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 263 | $1,126 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 49 | $1,087 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 82 | $1,031 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 31 | $327 | $11 |
2016: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 103 | $24,670 | $237 |
| Return visit (30+ min) | 128 | $14,903 | $94 |
| Biopsy of large bowel using a flexible endoscope | 136 | $14,006 | $103 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 80 | $6,834 | $81 |
| New patient visit (45+ min) | 34 | $4,560 | $134 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,478 | $213 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $4,024 | $212 |
| New patient visit (30+ min) | 39 | $3,827 | $98 |
| Short return visit (20+ min) | 45 | $3,534 | $65 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,591 | $162 |
| Long return visit (40+ min) | 17 | $2,159 | $127 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 14 | $2,039 | $113 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 12 | $1,666 | $139 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,249 | $89 |
| Injection beneath lining of large bowel using a flexible endoscope | 53 | $1,189 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,029 | $64 |
2015: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 105 | $30,352 | $284 |
| Biopsy of large bowel using a flexible endoscope | 183 | $29,834 | $162 |
| Return visit (30+ min) | 107 | $13,326 | $100 |
| New patient visit (45+ min) | 49 | $7,186 | $147 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 61 | $5,745 | $94 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 22 | $5,138 | $234 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $4,483 | $236 |
| New patient visit (30+ min) | 42 | $4,091 | $97 |
| Short return visit (20+ min) | 29 | $1,989 | $62 |
| Long return visit (40+ min) | 15 | $1,761 | $117 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,224 | $94 |
| Injection beneath lining of large bowel using a flexible endoscope | 43 | $1,190 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,087 | $68 |
2014: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 93 | $24,719 | $266 |
| Biopsy of large bowel using a flexible endoscope | 125 | $19,161 | $153 |
| Return visit (30+ min) | 92 | $11,374 | $95 |
| New patient visit (30+ min) | 70 | $6,540 | $93 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 25 | $6,022 | $241 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 47 | $3,962 | $81 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $3,167 | $226 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $2,087 | $190 |
| Long return visit (40+ min) | 14 | $2,000 | $133 |
| New patient visit (15+ min) | 22 | $1,398 | $64 |
| Short return visit (20+ min) | 17 | $1,362 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,191 | $63 |
| Injection beneath lining of large bowel using a flexible endoscope | 34 | $894 | $26 |
2013: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 59 | $16,139 | $269 |
| Biopsy of large bowel using a flexible endoscope | 78 | $11,273 | $145 |
| Return visit (30+ min) | 84 | $10,165 | $98 |
| New patient visit (30+ min) | 56 | $5,277 | $94 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $4,593 | $115 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $3,641 | $243 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $2,951 | $155 |
| Short return visit (20+ min) | 33 | $2,699 | $64 |
| Long return visit (40+ min) | 14 | $1,629 | $116 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,436 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,241 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,133 | $87 |
| Injection beneath lining of large bowel using a flexible endoscope | 22 | $608 | $26 |
Drugs they prescribed that Part D paid
$219,626
Pharmacies billed $219,626 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,000 generic and 294 brand-name prescriptions · $219,626 in drug cost · 29 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 37 | $51,602 | $1,395 |
| Creon | 17 | $39,029 | $2,296 |
| Sod Sulf-Potass Sulf-Mag Sulf | 360 | $23,535 | $65 |
| Vemlidy | 13 | $21,814 | $1,678 |
| Dexlansoprazole Dr | 42 | $18,160 | $432 |
See all 20 drugs
| Linzess | 37 | $51,602 | $1,395 |
| Creon | 17 | $39,029 | $2,296 |
| Sod Sulf-Potass Sulf-Mag Sulf | 360 | $23,535 | $65 |
| Vemlidy | 13 | $21,814 | $1,678 |
| Dexlansoprazole Dr | 42 | $18,160 | $432 |
| Lubiprostone | 36 | $6,457 | $179 |
| Colesevelam | 41 | $5,640 | $138 |
| Mesalamine | 12 | $4,852 | $404 |
| Budesonide Ec | 14 | $3,122 | $223 |
| Sucralfate | 24 | $3,006 | $125 |
| Omeprazole | 198 | $2,807 | $14 |
| Famotidine | 150 | $2,587 | $17 |
| Esomeprazole Magnesium | 19 | $1,319 | $69 |
| Ondansetron Odt | 38 | $579 | $15 |
| Peg 3350-Electrolyte | 29 | $470 | $16 |
| Pantoprazole | 36 | $455 | $13 |
| Mirtazapine | 11 | $264 | $24 |
| Buspirone | 44 | $192 | $4 |
| Nortriptyline | 13 | $160 | $12 |
| Amoxicillin-Clavulanate Potass | 11 | $56 | $5 |
Year by year
| 2024 | 1,294 | 587 | None | 23% | $219,626 |
| 2023 | 1,062 | 478 | 0% (0) | 27% | $216,729 |
| 2022 | 970 | 363 | 0% (0) | 32% | $192,520 |
| 2021 | 1,126 | 463 | 0% (0) | 40% | $416,699 |
| 2020 | 1,025 | 399 | None | 44% | $465,305 |
| 2019 | 1,052 | 477 | None | None | $450,957 |
| 2018 | 939 | 436 | None | 39% | $214,233 |
| 2017 | 898 | 416 | None | None | $255,547 |
| 2016 | 775 | 339 | None | 47% | $254,944 |
| 2015 | 705 | 315 | None | None | $332,591 |
| 2014 | 640 | 321 | 0% (0) | None | $85,023 |
| 2013 | 458 | 211 | None | None | $55,051 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Creon | 16 | $36,311 | $2,269 |
| Linzess | 14 | $22,594 | $1,614 |
| Sod Sulf-Potass Sulf-Mag Sulf | 237 | $18,491 | $78 |
| Vemlidy | 12 | $17,932 | $1,494 |
| Mesalamine | 13 | $13,791 | $1,061 |
| Lubiprostone | 37 | $12,629 | $341 |
| Dexlansoprazole Dr | 20 | $11,062 | $553 |
| Sucralfate | 26 | $5,010 | $193 |
| Budesonide Ec | 11 | $4,109 | $374 |
| Colesevelam | 16 | $3,843 | $240 |
| Chlordiazepoxide-Clidinium | 11 | $3,674 | $334 |
| Omeprazole | 195 | $3,548 | $18 |
| Famotidine | 110 | $3,168 | $29 |
| Ursodiol | 14 | $1,083 | $77 |
| Peg 3350-Electrolyte | 40 | $998 | $25 |
| Esomeprazole Magnesium | 13 | $769 | $59 |
| Pantoprazole | 37 | $750 | $20 |
| Nortriptyline | 19 | $514 | $27 |
| Buspirone | 41 | $366 | $9 |
| Ondansetron Odt | 25 | $317 | $13 |
2022: 21 drugs
| Creon | 19 | $38,940 | $2,049 |
| Linzess | 18 | $18,198 | $1,011 |
| Lubiprostone | 30 | $14,582 | $486 |
| Suprep | 125 | $14,435 | $115 |
| Dexilant | 26 | $13,923 | $536 |
| Mesalamine | 12 | $9,676 | $806 |
| Amitiza | 19 | $8,297 | $437 |
| Sucralfate | 37 | $4,699 | $127 |
| Omeprazole | 212 | $4,402 | $21 |
| Colesevelam | 12 | $3,879 | $323 |
| Ursodiol | 18 | $3,301 | $183 |
| Famotidine | 84 | $2,888 | $34 |
| Budesonide Ec | 16 | $2,457 | $154 |
| Cholestyramine | 24 | $2,298 | $96 |
| Sod Sulf-Potass Sulf-Mag Sulf | 11 | $1,013 | $92 |
| Mirtazapine | 25 | $983 | $39 |
| Pantoprazole | 38 | $822 | $22 |
| Ondansetron Odt | 20 | $636 | $32 |
| Peg 3350-Electrolyte | 23 | $463 | $20 |
| Nortriptyline | 18 | $291 | $16 |
| Buspirone | 18 | $136 | $8 |
2021: 24 drugs
| Linzess | 44 | $34,741 | $790 |
| Creon | 21 | $32,773 | $1,561 |
| Dexilant | 38 | $26,405 | $695 |
| Suprep | 213 | $23,556 | $111 |
| Mesalamine | 18 | $15,610 | $867 |
| Amitiza | 22 | $12,535 | $570 |
| Lubiprostone | 15 | $5,776 | $385 |
| Colesevelam | 17 | $5,233 | $308 |
| Sucralfate | 53 | $4,804 | $91 |
| Omeprazole | 221 | $4,759 | $22 |
| Esomeprazole Magnesium | 23 | $4,605 | $200 |
| Clenpiq | 27 | $4,347 | $161 |
| Famotidine | 83 | $2,369 | $29 |
| Cholestyramine | 15 | $2,256 | $150 |
| Budesonide Ec | 13 | $2,130 | $164 |
| Ursodiol | 17 | $1,421 | $84 |
| Pantoprazole | 45 | $1,132 | $25 |
| Mirtazapine | 18 | $840 | $47 |
| Tenofovir Disoproxil | 11 | $757 | $69 |
| Peg 3350-Electrolyte | 27 | $481 | $18 |
| Diphenoxylate-Atropine | 11 | $468 | $43 |
| Nortriptyline | 24 | $362 | $15 |
| Ondansetron Odt | 20 | $341 | $17 |
| Amitriptyline | 14 | $190 | $14 |
2020: 19 drugs
| Amitiza | 93 | $51,784 | $557 |
| Dexilant | 72 | $40,943 | $569 |
| Creon | 26 | $34,005 | $1,308 |
| Suprep | 183 | $19,190 | $105 |
| Linzess | 15 | $15,559 | $1,037 |
| Budesonide Ec | 17 | $6,166 | $363 |
| Omeprazole | 191 | $3,926 | $21 |
| Cholestyramine | 34 | $3,516 | $103 |
| Ursodiol | 17 | $3,182 | $187 |
| Famotidine | 73 | $2,283 | $31 |
| Sucralfate | 27 | $1,227 | $45 |
| Pantoprazole | 45 | $1,157 | $26 |
| Tenofovir Disoproxil | 12 | $975 | $81 |
| Esomeprazole Magnesium | 12 | $793 | $66 |
| Ondansetron Odt | 15 | $495 | $33 |
| Diphenoxylate-Atropine | 11 | $430 | $39 |
| Nortriptyline | 19 | $286 | $15 |
| Peg 3350-Electrolyte | 19 | $267 | $14 |
| Amitriptyline | 11 | $161 | $15 |
2019: 20 drugs
| Dexilant | 69 | $41,099 | $596 |
| Creon | 33 | $40,871 | $1,239 |
| Amitiza | 71 | $35,925 | $506 |
| Suprep | 228 | $22,806 | $100 |
| Linzess | 18 | $17,879 | $993 |
| Mesalamine | 11 | $13,869 | $1,261 |
| Ursodiol | 24 | $5,951 | $248 |
| Budesonide Ec | 12 | $5,422 | $452 |
| Colesevelam | 12 | $3,858 | $321 |
| Omeprazole | 140 | $3,464 | $25 |
| Cholestyramine | 30 | $3,398 | $113 |
| Esomeprazole Magnesium | 13 | $2,699 | $208 |
| Famotidine | 57 | $1,423 | $25 |
| Sucralfate | 30 | $1,135 | $38 |
| Pantoprazole | 47 | $890 | $19 |
| Entecavir | 11 | $786 | $71 |
| Peg 3350-Electrolyte | 35 | $581 | $17 |
| Gavilyte-N | 29 | $408 | $14 |
| Amitriptyline | 19 | $294 | $15 |
| Nortriptyline | 17 | $216 | $13 |
2018: 16 drugs
| Amitiza | 81 | $41,323 | $510 |
| Creon | 23 | $28,391 | $1,234 |
| Dexilant | 29 | $21,039 | $725 |
| Budesonide Ec | 20 | $11,862 | $593 |
| Suprep | 56 | $5,329 | $95 |
| Omeprazole | 129 | $2,810 | $22 |
| Cholestyramine | 20 | $2,620 | $131 |
| Peg 3350-Electrolyte | 134 | $2,215 | $17 |
| Sucralfate | 21 | $1,862 | $89 |
| Gavilyte-N | 62 | $998 | $16 |
| Famotidine | 33 | $714 | $22 |
| Pantoprazole | 40 | $684 | $17 |
| Amitriptyline | 22 | $390 | $18 |
| Peg 3350-Electrolyte | 18 | $166 | $9 |
| Gavilyte-C | 13 | $123 | $9 |
| Ondansetron Odt | 16 | $108 | $7 |
2017: 21 drugs
| Lialda | 24 | $28,886 | $1,204 |
| Amitiza | 44 | $23,920 | $544 |
| Dexilant | 42 | $22,287 | $531 |
| Mesalamine | 14 | $16,564 | $1,183 |
| Budesonide Ec | 20 | $14,778 | $739 |
| Creon | 12 | $13,078 | $1,090 |
| Welchol | 16 | $6,224 | $389 |
| Esomeprazole Magnesium | 11 | $4,470 | $406 |
| Cholestyramine | 27 | $3,435 | $127 |
| Omeprazole | 128 | $2,697 | $21 |
| Peg 3350-Electrolyte | 175 | $2,522 | $14 |
| Sucralfate | 34 | $948 | $28 |
| Gavilyte-N | 56 | $942 | $17 |
| Famotidine | 51 | $843 | $17 |
| Pantoprazole | 26 | $570 | $22 |
| Amitriptyline | 21 | $369 | $18 |
| Dicyclomine | 13 | $285 | $22 |
| Nortriptyline | 19 | $276 | $15 |
| Ranitidine | 15 | $208 | $14 |
| Peg 3350-Electrolyte | 15 | $141 | $9 |
| Ondansetron Odt | 13 | $106 | $8 |
2016: 16 drugs
| Lialda | 24 | $25,203 | $1,050 |
| Budesonide Ec | 35 | $19,355 | $553 |
| Amitiza | 41 | $19,186 | $468 |
| Dexilant | 38 | $18,359 | $483 |
| Creon | 14 | $14,184 | $1,013 |
| Welchol | 29 | $8,799 | $303 |
| Peg 3350-Electrolyte | 123 | $1,858 | $15 |
| Omeprazole | 116 | $1,816 | $16 |
| Moviprep | 13 | $1,150 | $88 |
| Famotidine | 47 | $1,019 | $22 |
| Gavilyte-N | 53 | $902 | $17 |
| Pantoprazole | 22 | $632 | $29 |
| Sucralfate | 22 | $423 | $19 |
| Amitriptyline | 25 | $291 | $12 |
| Nortriptyline | 12 | $181 | $15 |
| Polyethylene Glycol 3350 | 12 | $130 | $11 |
2015: 19 drugs
| Lialda | 16 | $20,028 | $1,252 |
| Budesonide Ec | 11 | $11,813 | $1,074 |
| Amitiza | 35 | $10,737 | $307 |
| Creon | 12 | $10,037 | $836 |
| Dexilant | 18 | $7,160 | $398 |
| Welchol | 18 | $6,048 | $336 |
| Prevacid | 12 | $5,314 | $443 |
| Peg 3350-Electrolyte | 128 | $2,257 | $18 |
| Omeprazole | 107 | $1,526 | $14 |
| Moviprep | 17 | $1,363 | $80 |
| Famotidine | 49 | $1,003 | $20 |
| Gavilyte-N | 46 | $863 | $19 |
| Pantoprazole | 21 | $500 | $24 |
| Polyethylene Glycol 3350 | 14 | $321 | $23 |
| Sucralfate | 16 | $310 | $19 |
| Diphenoxylate-Atropine | 13 | $293 | $23 |
| Trilyte With Flavor Packets | 12 | $235 | $20 |
| Amitriptyline | 20 | $158 | $8 |
| Nortriptyline | 13 | $116 | $9 |
2014: 17 drugs
| Lialda | 16 | $16,769 | $1,048 |
| Budesonide Ec | 17 | $11,890 | $699 |
| Amitiza | 39 | $10,933 | $280 |
| Dexilant | 11 | $4,634 | $421 |
| Carafate | 20 | $4,629 | $231 |
| Welchol | 16 | $3,897 | $244 |
| Peg-3350 | 128 | $2,183 | $17 |
| Moviprep | 25 | $1,981 | $79 |
| Omeprazole | 83 | $1,338 | $16 |
| Gavilyte-N | 56 | $1,027 | $18 |
| Famotidine | 36 | $655 | $18 |
| Pantoprazole | 21 | $526 | $25 |
| Polyethylene Glycol 3350 | 11 | $384 | $35 |
| Trilyte With Flavor Packets | 19 | $374 | $20 |
| Diphenoxylate-Atropine | 19 | $222 | $12 |
| Nortriptyline | 11 | $107 | $10 |
| Amitriptyline | 14 | $65 | $5 |
2013: 14 drugs
| Budesonide Ec | 12 | $7,532 | $628 |
| Amitiza | 19 | $6,239 | $328 |
| Carafate | 17 | $5,428 | $319 |
| Welchol | 14 | $2,302 | $164 |
| Omeprazole | 63 | $1,401 | $22 |
| Cholestyramine | 24 | $1,360 | $57 |
| Moviprep | 19 | $1,339 | $70 |
| Peg-3350 With Flavor Packs | 69 | $1,272 | $18 |
| Famotidine | 23 | $784 | $34 |
| Pantoprazole | 18 | $464 | $26 |
| Gavilyte-N | 24 | $432 | $18 |
| Diphenoxylate-Atropine | 21 | $244 | $12 |
| Nortriptyline | 17 | $227 | $13 |
| Trilyte With Flavor Packets | 11 | $212 | $19 |
Money from drug and device companies
$493 in 2025
| 2025 | 3 | 16 | None | $493 |
| 2024 | 1 | 2 | None | $27 |
| 2023 | 1 | 4 | None | $149 |
| 2020 | 2 | 2 | None | $206 |
| 2019 | 1 | 1 | None | $91 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $236 | 7 payments
|
| Lilly USA | Omvoh | $146 | 5 payments
|
| Abbvie | Linzess | $112 | 4 payments
|
See all 16 published payments
| Janssen Biotech | Meals · 2025-10-29 | Tremfya | $37 |
| Abbvie | Meals · 2025-10-18 | Rinvoq | $27 |
| Janssen Biotech | Meals · 2025-10-13 | Tremfya | $19 |
| Abbvie | Meals · 2025-09-05 | Linzess | $31 |
| Lilly USA | Meals · 2025-08-05 | Omvoh | $29 |
| Lilly USA | Meals · 2025-07-14 | Omvoh | $35 |
| Janssen Biotech | Education · 2025-07-02 | Tremfya | $99 |
| Abbvie | Meals · 2025-07-02 | Linzess | $25 |
| Lilly USA | Meals · 2025-06-24 | Omvoh | $33 |
| Janssen Biotech | Meals · 2025-06-04 | Tremfya | $16 |
| Abbvie | Meals · 2025-05-09 | Rinvoq | $28 |
| Janssen Biotech | Meals · 2025-05-02 | Tremfya | $29 |
| Lilly USA | Meals · 2025-04-01 | Omvoh | $35 |
| Janssen Biotech | Meals · 2025-03-12 | Tremfya | $20 |
| Lilly USA | Meals · 2025-03-06 | Omvoh | $14 |
| Janssen Biotech | Meals · 2025-02-28 | Tremfya | $14 |
See earlier years (2024, 2023, 2020, 2019)
2024: $27
| Abbvie | Creon | $27 | 2 payments
|
2023: $149
| Abbvie | Linzess | $149 | 4 payments
|
2020: $206
| Takeda Pharmaceuticals U.S.A. | Motegrity | $122 | 1 payment
|
| Pfizer | Xeljanz | $84 | 1 payment
|
2019: $91
| AbbVie | None | $91 | 1 payment
|
Professional record
- NPI
- 1043394893
- Licence
- CA A75871California A75871: Current · expires 2027-04-30
- Trained
- State University of Ny Upstate Medical University, 1995
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-10-25
- NPI last updated
- 2020-05-27
- NPI record certified
- 2020-05-27
This is when the NPI record was last certified, not a medical board exam.